On immunohistochemical analysis of the initial biopsy (Table 1), the endometrioid carcinoma component was diffuse positive for ER and PgR, but negative for TTF-1 and GATA-3 (Fig. 3b, c). The gene discussed is PGR; the disease is endometrioid adenocarcinoma.